Rare Breast Tumors
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 23 December 2024 | Viewed by 102
Special Issue Editors
Interests: breast cancer; breast surgery; oncology; oncoplastics
Interests: breast cancer; medical chemistry; tumors
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In most common types of breast cancer, such as no special type and invasive lobular carcinoma, the therapeutic approach is generally well defined. However, rare breast tumors, accounting for less than 2% of all breast cancer cases, present a diagnostic and therapeutic challenge. Because of their rarity, data on prognosis and evidence-based recommendations are lacking and there are no randomized studies to define the optimal neoadjuvant and adjuvant treatment.
The goal of this Special Issue is to highlight breast tumors with rare histology, with a focus on clinical and pathological characteristics as well as responses to different therapeutic strategies. Original research articles and reviews are welcome.
Prof. Dr. Maggie Banys-Paluchowski
Prof. Dr. Maria Luisa Gasparri
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- rare breast tumors
- rare histology
- breast cancer
- phylloides tumor
- male breast cancer
- CUP syndrome
- breast implant-associated anaplastic large cell lymphoma
- diabetic mastopathy
- metaplastic breast cancer
- apocrine breast cancer
- inflammatory breast cancer
- medullary breast cancer
- mucinous breast cancer
- adenoid cystic carcinoma of the breast
- lymphoma of the breast
- basal type breast cancer
- angiosarcoma of the breast breast neuroendocrine tumors
- brain metastases
- PET imaging agents (FES, FFNP, and FDHT)
- microinvasive breast cancer
- supraclavicular and contralateral axillary lymph node involvement
- ectopic breast tissue
- pregnancy-associated breast cancer
